NDC product
SEROQUEL XR
NDC 0310-0284 · AstraZeneca Pharmaceuticals LP
Key facts
| Product NDC | 0310-0284 |
|---|---|
| Proprietary name | SEROQUEL |
| Nonproprietary name | quetiapine |
| Substances | QUETIAPINE FUMARATE |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | AstraZeneca Pharmaceuticals LP |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA022047 |
| Pharmacologic classes | Atypical Antipsychotic [EPC] |
| Marketing start | Jul 16, 2007 |
| Marketing end | Feb 28, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory